October 12, 2018
An oral therapy called ibudilast significantly reduced the rate of brain tissue loss in patients with progressive multiple sclerosis (MS), according to the results of a recent phase II trial. The findings, published in the New England Journal of Medicine, support further study of the drug to determine if they might also translate […]